期刊文献+

细胞周期关键分子标记物在HPV阳性宫颈癌中的表达 被引量:5

Expression of key cell cycle markers in squamous cell carcinoma of the cervix positive in human papillomavirus: a comparative study between Chinese and Australian populations
原文传递
导出
摘要 目的研究人乳头状瘤病毒(HPV)E6、E7作用位点的各种细胞周期蛋白在宫颈癌的表达情况。方法选择73例HPV16阳性的宫颈鳞癌癌组织标本,其中35例来自澳大利亚,38例来自中国。采用半定量的免疫组化方法检测p53、pRb、p16INK4A、p21CIP1/WAF1、p27KIP1和细胞周期素D1(cyclin D1)的表达情况。结果两组患者在平均年龄、淋巴结转移、肿瘤细胞分化程度方面的差异无统计学意义,但中国组较澳大利亚组进展期宫颈癌(>Ⅱa期)患者为多(P=0.007)。澳大利亚组宫颈癌组织p53的阳性表达率及pRb、p21和p27的上调率分别为3%、56%、63%和34%,中国组分别为23%、89%、97%和89%,两组癌组织中上述四种细胞周期蛋白的表达情况差异有统计学意义。p16和cyclin D1的上调率在澳大利亚组分别为97%和3%,在中国组分别为和100%和12%,两组比较差异无统计学意义。两组资料合并,p53总的阳性表达率为13%,pRb、p16、p21、p27和cyclinD1总的上调率分别为74%、99%、81%、63%和7%。结论HPV16阳性的宫颈癌明显存在pRb、p16、p21和p27的过度表达,而中国组宫颈癌p53阳性表达率和pRb、p21、p27的过度表达率比澳大利亚组明显增高,这提示HPV诱导宫颈癌的分子学途径复杂,有必要在不同人种进行进一步研究。 Objective To investigate the patterns of expression of key cell cycle proteins targeting on the human papillomavirus ( HPV ) sites E6 and E7 in cervical carcinoma. Methods Semiquantitative immunohistochemistry was used to determine the expression of the cell cycle regulatory factor p53, retinoblastoma gene product pRb, cyclin-dependent kinase inhibitors p21^CIP1/WAF1 ( p21 ) , pl6^INK4A ( p21 ), and p27^KIP1 ( p21 ), and cyclin D1 targeting on the HPV sites E6 and E7 in 73 HPV 16-positive specimens of cervical squamous cell carcinoma, 35 from Australia patients and 38 age, lymph node status, and grade of tumor-matched Chinese patients. Results There were no significant differences in age, lymph node status, and grade of tumor between the Chinese and Australian groups, however, the number of the patients in advanced stage ( 〉Stage IIa) was greater in the Chinese group than in the Australian group (19:7). The positive rate of p53 in the Australian group was 3% , significantly lower than that in the Chinese group (23% , P =0.028). The upregulation rate of pRb, p21, and p27 in the Australian group were 56% , 63% and 34% respectively, all significantly higher than those in the Chinese group ( 89% , 97% , and 89% respectively, P = 0. 01, P 〈 0. 001, and P 〈 0. 001 ). There were no significant differences in the upregulation rate of p16 and cyclin D1 expression rate between the Australian group and Chinese group (97% versus 100%, and 3% versus 12%, both P 〉0.05). In the combined data of both groups, the positive rate of p53 was 13%; and the upregulation rates of pRb, pl6, p21, p27, and cyclin D1 were 74% , 99%, 81%, 63% and 7% respectively. Conclusion Cervical carcinoma overexpresses pRb, pl6, p21, and p27. Tumors from Chinese patients are significantly more likely to be positive in p53 and to have upregulated pRb, p21, and p27 than their Australian counterparts. The molecular pathways to human papillomavirus-induced cervical cancer may be influenced by ethnicity and further investigation is necessary.
出处 《中华医学杂志》 CAS CSCD 北大核心 2006年第5期312-316,共5页 National Medical Journal of China
关键词 乳头状瘤病毒 宫颈肿瘤 蛋白 细胞周期 Papillomavirus, human Cervix neoplasms Egg white Cell cycle
  • 相关文献

参考文献24

  • 1zur Hausen H. Oncogenic DNA viruses. Oncogene, 2001,20:7820-7823.
  • 2Cheung TH, Lo KW, Yu MM, et al. Aberrant expression of p21( WAF1/CIP1 ) and p27( KIP1 ) in cervical carcinoma. Cancer Lett,2001,172:93-98.
  • 3Kim YT, Cho NH, Park SW, et al. Underexpression of cyclin-dependent kinase (CDK) inhibitors in cervical carcinoma. Gynecol Oncol, 1998,71:38-45.
  • 4Skomedal H, Kristensen GB, Lie AK, et al. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4,cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol Oncol,1999,73:223-228.
  • 5Andl T, Kahn T, Pfuhl A, et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res,1998,58:5-13.
  • 6Milde-Langosch K, Riethdorf S. Role of cell-cycle regulatory proteins in gynecological cancer. J Cell Physiol, 2003,196: 224-244.
  • 7Milde-Langosch K, Mbrecht K, Joram S, et al. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer, 1995,63:639-645.
  • 8刘继红,黄欣,廖革望,李俊东,李艳芳,李孟达,Barbara Rose,Carol Thompson.中国和澳大利亚宫颈癌患者人乳头状瘤病毒感染及其他危险因素的对比研究[J].中华医学杂志,2003,83(9):748-752. 被引量:27
  • 9Sano T, Oyama T, Kashiwabara K, et al. Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia. Pathol Int, 1998,48:580-585.
  • 10Erber R, Klein W, Andl T, et al. Aberrant p21 ( CIP1/WAF1 )protein accumulation in head-and-neck cancer. Int J Cancer, 1997,74:383-389.

二级参考文献8

  • 1刘宝印,李洁,De,李力,龚林,王宏,杨学志,林玉纯.我国人乳头瘤病毒58型感染与宫颈癌的关系[J].中华实验和临床病毒学杂志,1996,10(2):118-121. 被引量:15
  • 2Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst, 1995,87:796-802.
  • 3Lai HC, Sun CA, Yu MH, et al. Favorable clinical outcome of cervical cancers infected with human papillomavirus type 58 and related types. Int J Cancer, 1999,84:553-557.
  • 4Lo WK, Wong YF, Chan KM, et al. Prevalence of human papillomavirus in cervical cancer: a multicenter study in China. Int J Cancer, 2002,100:327-331.
  • 5Gravitt PE, Peyton CL, Apple RJ, et al. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol, 1998,36:3020-3027.
  • 6Pao CC, Kao SM, Tang GC, et al. Human papillomavirus and cervical carcinoma in China and Taiwan. Lancet, 1993,342: 937-943.
  • 7Krul EJ, Van De Vijver MJ, Schuuring E, et al. Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk country. Int J Gynecol Cancer, 1999,9:206-211.
  • 8Huang S, Afonina I, Beth AM, et al. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer, 1997,70:408-411.

共引文献26

同被引文献40

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部